Boditech Med Inc. (KOSDAQ:206640)

Boditech Med Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	47,944	42,494	26,262	38,817	24,045
Short-Term Investments	11,790	20,333	8,287	7,801	15,660
Trading Asset Securities	1,981	13,370	25,910	21,850	19,463
Cash & Short-Term Investments	61,715	76,198	60,459	68,469	59,168
Cash Growth	-19.01%	26.03%	-11.70%	15.72%	138.13%
Accounts Receivable	29,274	26,507	22,085	24,708	33,868
Other Receivables	1,613	1,769	990.41	1,869	1,473
Receivables	31,328	28,602	23,442	26,846	35,611
Inventory	38,754	31,603	30,849	33,410	24,063
Prepaid Expenses	634.39	383.61	388.69	382.14	296.38
Other Current Assets	3,391	1,893	2,168	1,975	2,301
Total Current Assets	135,822	138,679	117,307	131,083	121,440
Property, Plant & Equipment	61,871	56,441	58,158	45,360	30,790
Long-Term Investments	46,227	21,851	10,187	7,464	4,545
Goodwill	316.3	316.3	316.3	316.3	316.3
Other Intangible Assets	4,045	3,823	4,135	4,156	4,118
Long-Term Deferred Tax Assets	2,129	2,263	1,462	1,549	401.95
Long-Term Deferred Charges	1,761	1,381	981.39	-	228.59
Other Long-Term Assets	1,610	2,285	2,130	1,559	647.92
Total Assets	254,674	227,902	195,656	192,242	163,475
Accounts Payable	5,458	5,238	1,580	6,417	6,146
Accrued Expenses	6,345	5,538	5,050	4,485	3,808
Short-Term Debt	6,729	7,059	3,976	2,350	5,460
Current Portion of Long-Term Debt	266.64	200.06	1,000	1,200	2,281
Current Portion of Leases	851.8	658.57	748.91	850.27	723.98
Current Income Taxes Payable	3,869	4,346	771.13	7,125	10,959
Other Current Liabilities	3,865	4,225	2,994	4,686	3,924
Total Current Liabilities	27,386	27,264	16,121	27,113	33,301
Long-Term Debt	1,833	2,100	2,300	1,600	2,800
Long-Term Leases	1,406	550.43	870.04	865.45	659.99
Long-Term Deferred Tax Liabilities	444.27	522.58	1,053	1,052	417.9
Other Long-Term Liabilities	552.41	47.9	480.86	378.67	195.04
Total Liabilities	31,622	30,485	20,825	31,009	37,374
Common Stock	23,487	23,487	23,487	23,487	23,487
Additional Paid-In Capital	19,912	19,677	19,677	19,662	20,207
Retained Earnings	186,207	163,342	140,603	120,722	80,963
Treasury Stock	-24,429	-21,573	-21,587	-14,539	-5,813
Comprehensive Income & Other	5,093	1,265	1,375	1,758	1,015
Total Common Equity	210,269	186,198	163,555	151,088	119,859
Minority Interest	12,783	11,218	11,276	10,145	6,242
Shareholders' Equity	223,053	197,417	174,831	161,233	126,101
Total Liabilities & Equity	254,674	227,902	195,656	192,242	163,475
Total Debt	11,087	10,568	8,895	6,866	11,925
Net Cash (Debt)	50,629	65,630	51,564	61,603	47,243
Net Cash Growth	-22.86%	27.28%	-16.30%	30.40%	433.06%
Net Cash Per Share	2307.55	2987.51	2305.67	2688.08	2051.84
Filing Date Shares Outstanding	21.78	21.97	21.97	22.59	23.04
Total Common Shares Outstanding	21.78	21.97	21.97	22.59	23.04
Working Capital	108,437	111,415	101,186	103,970	88,139
Book Value Per Share	9653.26	8475.58	7445.22	6688.05	5201.62
Tangible Book Value	205,909	182,059	159,104	146,616	115,425
Tangible Book Value Per Share	9453.05	8287.18	7242.59	6490.08	5009.20
Land	13,250	13,017	12,620	10,337	7,177
Buildings	31,605	31,557	31,225	20,587	15,361
Machinery	46,190	41,449	39,301	27,937	22,986
Construction In Progress	7,132	2,796	1,508	7,755	2,637

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.